The IPO window is open, the market for new issues is strong and Harris & Harris Group has a strong pipeline of disruptive technologies it plans to push forward, said the early stage venture capital company's CEO Doug Jamison. Jamison said its metabolomic diagnostic company Metabolon could potentially be taken public in the second half of 2014. He said the company has recently added to its investment in waterproofing technology company HZO, which is growing rapidly and could be cash flow positive in early 2015. Finally, Jamison said that Harris & Harris Group holds onto the shares of the companies it builds, as opposed to selling out during the IPO. TheStreet's Gregg Greenberg reports from New York.